← Back to Search

Device

tunneled pleural catheter for Congestive Heart Failure (TREAT-CHF Trial)

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post-enrollment
Awards & highlights

TREAT-CHF Trial Summary

This trial is studying whether a tunneled pleural catheter (TPC) can improve quality of life for people with congestive heart failure (CHF) who have recurrent symptomatic pleural effusions that are not helped by diuretics.

Eligible Conditions
  • Congestive Heart Failure
  • Chronic Pleural Effusions
  • Shortness of Breath

TREAT-CHF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in quality of life scores from baseline as measured by the Minnesota Living with Heart Failure Questionnaire
Incidence of hospitalizations and emergency room encounters
Secondary outcome measures
All cause mortality
Change from baseline serum albumin
Change from baseline serum creatinine
+8 more

TREAT-CHF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This group will receive placement of a tunneled pleural catheter to drain their recurrent, chronic, and symptomatic pleural effusion in addition to their usual medication therapy.
Group II: Usual CareActive Control1 Intervention
The control group will continue with medical therapy by their referring physician and serial thoracenteses when clinically appropriate.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,521 Previous Clinical Trials
10,278,936 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited for this trial?

"Affirmative, the information available on clinicaltrials.gov reveals that this research trial is still enrolling patients. Initially published October 1st 2020, it has recently been updated May 18th 2022 and seeks to recruit 210 individuals from a single site."

Answered by AI

Is enrollment open for this experiment?

"Per the listings on clinicaltrials.gov, this research study is in a recruitment phase and has been since October 1st 2020. The information was last modified on May 18th 2022."

Answered by AI

What are the intended outcomes of this research?

"The primary evaluation metric of this trial across a year-long period will be the amount of hospitalizations and emergency room visits. Secondary outcomes include incidence of pleural procedures, time to pleurodesis among those who achieved it, and classifications according to New york Heath Association's Functional Class (I, II, III or IV)."

Answered by AI
~0 spots leftby Oct 2024